Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Modern Pathology

• Publication date

  2005-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/modpathol.3800372PMID 15920558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Akt pathway: molecular targets for anti-cancer drug development.

  2004cited by this paper
• Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling.

  2004cited by this paper
• Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor‐κB signaling

  2004cited by this paper
• Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor–environment interaction in metastasis of head and neck squamous cell carcinoma

  2004cited by this paper
• Morphoproteomic and pharmacoproteomic correlates in hormone-receptor-negative breast carcinoma cell lines.

  2004cited by this paper
• Targets and mechanisms for the regulation of translation in malignant transformation

  2004cited by this paper
• Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases

  2004cited by this paper
• Differential Apoptotic Response to the Proteasome Inhibitor Bortezomib (VELCADETM, PS-341) in Bax-Deficient and p21-Deficient Colon Cancer Cells

  2003cited by this paper
• Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.

  2003cited by this paper
• Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas.

  2003cited by this paper
• The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells.

  2003cited by this paper
• Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis

  2003cited by this paper
• Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.

  2003cited by this paper
• Implication of protein kinase B/Akt and Bcl-2/Bcl-XL suppression by the farnesyl transferase inhibitor SCH66336 in apoptosis induction in squamous carcinoma cells.

  2003cited by this paper
• p53 Protein and Ki-67 Overexpression in Urothelial Dysplasia of Bladder

  2002cited by this paper
• Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.

  2002cited by this paper
• Effect of different curcumin dosages on human gall bladder.

  2002cited by this paper
• Nuclear and cytoplasmic p53 expression in pharyngeal squamous cell carcinoma: Prognostic implications

  2002cited by this paper
• Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells.

  2001cited by this paper
• High expression levels of nuclear factor κB, IκB kinase α and Akt kinase in squamous cell carcinoma of the oral cavity

  2001cited by this paper
• Enhanced IκB kinase activity is responsible for the augmented activity of NF-κB in human head and neck carcinoma cells

  2001cited by this paper
• Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.

  2001cited by this paper
• Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase

  2001cited by this paper
• Head and neck cancer.

  2001cited by this paper
• Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.

  2001cited by this paper
• High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity.

  2001cited by this paper
• Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF‐κB

  2000cited by this paper
• Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition

  2000cited by this paper
• Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines.

  1999cited by this paper
• Proteasome inhibitors: a novel class of potent and effective antitumor agents.

  1999cited by this paper
• Different numerical chromosomal aberrations detected by FISH in oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Constitutive activation of transcription factors NF‐κB, AP‐1, and NF‐IL6 in human head and neck squamous cell carcinoma cell lines that express pro‐inflammatory and pro‐angiogenic cytokines

  1999cited by this paper
• Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.

  1992cited by this paper
• Head and neck cancer.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• Proteins

  1987cited by this paper
• Epidemiological and diagnostic aspects of oral squamous cell carcinoma.

  1984cited by this paper
• Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane

  1984cited by this paper
• Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins.

  1982cited by this paper
• [Some measures of proliferative activity in normal and leukoplakic buccal mucosa (author's transl)].

  1977cited by this paper
• Zur proliferationskinetik der normalen und leukoplakischen wangenmucosa

  1977cited by this paper

• Impact of HPV Status and AurkA Phe31Ile Polymorphism on The Response to Cetuximab Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC) Patients

  2020cites this paper
• TRAF3 and CYLD Gene Defects in HPV-Associated Head and Neck Cancer: Biomarker of Response and Indicator of Targets for New Therapies

  2018cites this paper
• TRAF3/CYLD mutations identify a distinct subset of human papillomavirus‐associated head and neck squamous cell carcinoma

  2017cites this paper
• Estudio del valor pronóstico de serpina e1 y su papel en el crecimiento y la diseminación metastática del carcinoma escamoso de cabeza y cuello

  2017influential citation
• Levels of circulating soluble receptor activator of NF-κB and interleukins-1 predicting outcome of locally advanced basal cell carcinoma

  2016cites this paper
• HNSCC Biomarkers Derived from Key Processes of Cancerogenesis

  2016cites this paper
• Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer.

  2016cites this paper
• NF-κB in cancer therapy

  2015cites this paper
• Title Systems biology-defined NF-κ B regulons , interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p 53 status

  2015cites this paper
• Cannabis smoke can be a major risk factor for early-age laryngeal cancer—a molecular signaling-based approach

  2015cites this paper
• The effects of anesthesia on the morphoproteomic expression of head and neck squamous cell carcinoma: a pilot study.

  2015cites this paper
• Understanding oral cancer at molecular level: The new frontier

  2015cites this paper
• Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers

  2015cites this paper
• Immunohistochemical expression of Cyclin D1 and NF-KB p65 in oral lichen planus and oral squamous cell carcinoma (Comparative study)

  2014cites this paper
• Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.

  2014cites this paper
• Overcoming Inherent Resistance to Proteasome Inhibitors in Head and Neck Cancer: Challenges and New Approaches

  2014cites this paper
• Suppressing the formation of lipid raft‐associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF‐1α‐induced invasion of human esophageal carcinoma cells

  2014cites this paper
• Impact of warm ischemia on phosphorylated biomarkers in head and neck squamous cell carcinoma.

  2014cites this paper
• Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis.

  2014cites this paper
• Clinical significance of head and neck squamous cell cancer biomarkers.

  2014cites this paper
• Clear Cell Sarcoma of Kidney: Morphoproteomic Analysis Reveals Genomic Correlates and Therapeutic Options

  2013cites this paper
• Overexpression of the nuclear factor‐kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy

  2013cites this paper
• Nuclear NF-κB expression correlates with outcome among patients with head and neck squamous cell carcinoma treated with primary chemoradiation therapy.

  2013cites this paper
• Paper miR-181 a regulates multiple pathways in hypopharyngeal squamous cell carcinoma

  2012cites this paper
• TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers

  2012cites this paper
• Fighting cancer from different signalling pathways: Effects of the proteasome inhibitor Bortezomib in combination with the polo-like-kinase-1-inhibitor BI2536 in SCCHN.

  2012influential citation
• miR-181a regulates multiple pathways in hypopharyngeal squamous cell carcinoma

  2012cites this paper
• Using NF-κB as a molecular target for theranostics in radiation oncology research

  2012cites this paper
• Efeito apoptótico do Celecoxib em linhagens celulares derivadas de carcinoma epidermóide de boca

  2011cites this paper
• Targeting the inflammatory pathways to enhance chemotherapy of cancer

  2011cites this paper
• FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.

  2011cites this paper
• Andrographolide Inhibits Oral Squamous Cell Carcinogenesis through NF-κB Inactivation

  2011influential citation
• Expression of classical NF‐κB pathway effectors in human ovarian carcinoma

  2010cites this paper
• Head and neck cancer: a step forward

  2010cites this paper
• Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

  2010cites this paper
• Correlation of NF-κB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma

  2010cites this paper
• Molecular Biology of Head & Neck Cancer: Risks and Pathways

  2009cites this paper
• Toll‐like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas

  2009cites this paper
• Inflammation and cancer: how friendly is the relationship for cancer patients?

  2009cites this paper
• Epigenetic loss of mucosa-associated lymphoid tissue 1 expression in patients with oral carcinomas.

  2009cites this paper
• Nuclear NF-κB p65 Phosphorylation at Serine 276 by Protein Kinase A Contributes to the Malignant Phenotype of Head and Neck Cancer

  2009cites this paper
• Morphogenomics and morphoproteomics: a role for anatomic pathology in personalized medicine.

  2009cites this paper
• Nuclear Transcription Factors and Signaling Pathways in Oral Cancer Metastasis

  2009cites this paper
• Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-κB and activator protein-1 related mechanisms

  2008cites this paper
• Bortezomib-Induced Apoptosis with Limited Clinical Response Is Accompanied by Inhibition of Canonical but not Alternative Nuclear Factor-κB Subunits in Head and Neck Cancer

  2008cites this paper
• The Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas.

  2008cites this paper
• Molecular biology of head and neck cancer: risks and pathways.

  2008cites this paper
• A signal network involving coactivated NF‐κB and STAT3 and altered p53 modulates BAX/BCL‐XL expression and promotes cell survival of head and neck squamous cell carcinomas

  2008cites this paper
• Systems biology-defined NF-κB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status

  2008cites this paper
• Anti-apoptotic and Pro-inflammatory Signaling in Cancer Cells: Status and Modulation by Chemotherapeutic Drugs

  2008cites this paper
• Clinical significance of nuclear factor (NF)-κB levels in urothelial carcinoma of the urinary bladder

  2008cites this paper
• The Potential Role of Intrinsic Hypoxia Markers as Prognostic Variables in Cancer

  2007cites this paper
• Phosphorylation of Akt ( Ser 473 ) Predicts Poor Clinical Outcome in Oropharyngeal Squamous Cell Cancer

  2007cites this paper
• Inhibitor-kappaB kinase in tumor promotion and suppression during progression of squamous cell carcinoma.

  2007cites this paper
• Expression of nuclear factor κB in human gastric carcinoma: relationship with IκBa and prognostic significance

  2007cites this paper
• Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance.

  2007cites this paper
• HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c‐myc during tumor formation

  2007cites this paper
• BASIC SCIENCE REVIEW

  2007cites this paper
• Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib.

  2007influential citation
• Nuclear factor-κB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101

  2007cites this paper
• Phosphorylation of Akt (Ser473) Predicts Poor Clinical Outcome in Oropharyngeal Squamous Cell Cancer

  2007cites this paper
• Inhibitor-κB Kinase in Tumor Promotion and Suppression During Progression of Squamous Cell Carcinoma

  2007influential citation
• A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status

  2007cites this paper
• Factor ( s ) in Head and Neck Squamous Carcinoma Cells B Activation by Serum κ Kinase and Aberrant Nuclear Factor-B κ Protein Kinase Casein Kinase 2 Mediates Inhibitor-Updated

  2006influential citation
• Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells.

  2006influential citation
• Morphoproteomic demonstration of constitutive nuclear factor-kappaB activation in glioblastoma multiforme with genomic correlates and therapeutic implications.

  2006cites this paper
• Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma.

  2006cites this paper
• Nuclear factor‐κB (nf‐κB) is frequently expressed in lung cancer and preneoplastic lesions

  2006cites this paper
• Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.

  2006cites this paper
• Nuclear Factor-kappaB Pathway as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma: Pharmaceutical and Molecular Validation in Human Cell Lines Using Velcade and siRNA/NF-κB.

  2005cites this paper
• Nuclear factor-kappaB pathway as a therapeutic target in head and neck squamous cell carcinoma: pharmaceutical and molecular validation in human cell lines using Velcade and siRNA/NF-kappaB.

  2005cites this paper
• Morphoproteomics: exposing protein circuitries in tumors to identify potential therapeutic targets in cancer patients

  2005cites this paper
• Nuclear Factor-kappaB Pathway as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma : Pharmaceutical and Molecular Validation in Human Cell Lines Using Velcade and siRNA / NF-κ

  2005cites this paper